International Working Group on Neurotransmitter Related Disorders

International Working Group on Neurotransmitter Related Disorders (iNTD) is a global network of clinicians, researchers, and healthcare professionals dedicated to improving the understanding, diagnosis, and treatment of neurotransmitter related disorders. These disorders are a group of rare, often inherited conditions that affect the brain's ability to communicate through chemicals known as neurotransmitters.

Overview

Neurotransmitter related disorders disrupt the normal functioning of neurotransmitters in the brain, leading to a wide range of symptoms including movement disorders, developmental delays, and various neurological symptoms. The International Working Group on Neurotransmitter Related Disorders aims to facilitate collaboration and share knowledge among experts in the field to advance research and improve patient care.

Mission

The mission of the iNTD is to:

• Promote international collaboration among scientists and clinicians working on neurotransmitter related disorders.
• Facilitate the sharing of information and resources to accelerate research and improve clinical care.
• Support the development of new diagnostic and therapeutic approaches for these conditions.
• Raise awareness and understanding of neurotransmitter related disorders among healthcare professionals and the public.

Research and Activities

The iNTD engages in a variety of activities to fulfill its mission, including:

• Hosting international conferences and workshops to bring together experts in the field.
• Developing and maintaining a patient registry to support research and improve understanding of these disorders.
• Providing educational resources and training for healthcare professionals.
• Supporting patients and families affected by neurotransmitter related disorders through information and advocacy.

Key Disorders

Some of the key neurotransmitter related disorders addressed by the iNTD include:

• Dopamine transporter deficiency syndrome
• Tyrosine hydroxylase deficiency
• Aromatic L-amino acid decarboxylase (AADC) deficiency
• Serotonin syndrome
• GABA transaminase deficiency

Membership

Membership in the iNTD is open to clinicians, researchers, and healthcare professionals involved in the study or care of patients with neurotransmitter related disorders. Members benefit from access to a network of experts, resources for research and clinical practice, and opportunities for collaboration.

Conclusion

The International Working Group on Neurotransmitter Related Disorders plays a crucial role in advancing the understanding and treatment of these complex conditions. Through its efforts, the iNTD aims to improve the lives of patients and families affected by neurotransmitter related disorders worldwide.

NIH genetic and rare disease info

• NIH info on International Working Group on Neurotransmitter Related Disorders

International Working Group on Neurotransmitter Related Disorders is a rare disease.